Riskpilot← Back to searchSign inGet full accessMedcap Oy
OYActiveY-tunnus 2371088-1Messipojantie 19-V27Medical specialists activities · NACE 8622Est. 20102 employees
Revenue 2024
EUR 297K
-5% vs 2023
EBITDA margin
32.0%
+40% vs 2023
Equity ratio
84.4%
Financial strength
Net profit 2024
EUR 59K
+47% vs 2023
| Revenue | EUR 297K | -5% |
| EBITDA | EUR 95K | +40% |
| Net profit | EUR 59K | +47% |
| Total assets | EUR 357K | -99% |
| Equity | EUR 301K | -99% |
| Employees | 2 | — |
Legal name
Medcap Oy
Y-tunnus number
2371088-1
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
15. marraskuuta 2010
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on erikoislääkäripalvelut.
Address
Messipojantie 19-V27
Phone
+3580405705786
Email
jthakkinen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 379 | 350 | 363 | 313 | 297 |
| Staff expenses | −196 | −243 | −252 | −172 | −138 |
| EBITDA | 133 | 65 | 44 | 68 | 95 |
| Depreciation & amort. | −6 | −5 | −16 | −19 | −22 |
| EBIT | 128 | 61 | 28 | 48 | 73 |
| Net financials | −0 | −0 | 3 | 1 | 0 |
| Profit before tax | 127 | 61 | 31 | 49 | 73 |
| Tax | 25 | 32 | 7 | 9 | 14 |
| Net profit | 102 | 29 | 24 | 40 | 59 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 223 | 244 | 286 | 28 968 | 357 |
| Equity | 188 | 237 | 243 | 26 377 | 301 |
| Long-term debt | 7 | — | 19 | 960 | 27 |
| Short-term debt | 28 | 7 | 24 | 1 631 | 28 |
| Total debt | 35 | 7 | 43 | 2 591 | 56 |
EBITDA margin
32.0%
This company
15.8%
Market median
+103% vs market
20202024
Equity ratio
84.4%
This company
38.2%
Market median
+121% vs market
20202024
Return on equity
19.5%
This company
18.4%
Market median
+6% vs market
20202024
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20202024
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JA Chief Executive Officer | Chief Executive Officer | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2010 | |
| Chairperson | 2010 | |
| Board of Directors | 2010 | |
| Board of Directors | 2010 | |
| Board of Directors | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medcap Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joonas Aukusti Häkkinen | Chief Executive Officer | 0 companies |
| Iida-Liina Linnea Häkkinen | Board of Directors | 0 companies |
| Jukka Tapio Häkkinen | Chairperson | 0 companies |
| Liisa Margit Häkkinen | Board of Directors | 0 companies |
| Anna-Sofia Katariina Häkkinen | Board of Directors | 0 companies |
| Sanni-Veera Marleena Häkkinen | Board of Directors | 0 companies |